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Stem cells have been used to investigate developmental processes and may be used as a therapeutic
source of material for regenerative medicine and cancer. Here we propose the use of human embryonic
stem cells, which represent a youthful phenotype, as models for experimentally investigating human
ageing.
 2008 Elsevier Inc. All rights reserved.1. Stem cells
All the cells of the human body are originally derived from the
fertilised egg cell. This cell multiplies by division and the progeny
cells differentiate to form all the somatic and germ cells of the
body. Human embryonic stem cells (ESC) were first isolated in
1998 (Thomson et al., 1998). Worldwide there are now a number
of laboratories growing human ESC lines. Human ESC are charac-
terised by their ability to form all the germ layers of the embryo
and therefore are called pluripotent, in contrast to somatic stem
cells (SSC) found in the various compartments of the body which
are thought to be restricted to forming cells within their particular
compartment and are thus termed multipotent. Both types of stem
cell, ESC and SSC, are able to replicate themselves (self-renew). So-
matic stem cells undergo replicative senescence in vitro, but ESC
are though to be able to self-renew indefinitely as well as main-
taining pluripotency (Amit et al., 2000). These two characteristics,
potency to form many cell types and self-renewal, have made ESC
of interest in various fields of biology and medicine, for example in
regenerative medicine looking to replace degenerated tissues in
diseases such as Myocardial Infarction, Alzheimer’s and Parkin-
son’s, and in cancer, as cancer may be caused by mutations in stem
cells.ll rights reserved.
H., Minger, S.L., Human embrCurrently, models of ageing are either of animals that may not
reflect human ageing or of degenerative diseases or differentiated
cells, where the ageing process, such as senescence, has already
commenced. This paper proposes that ESC may also be of great
use in ageing research providing a source of material on which to
test mechanisms of ageing.2. Isolation of human ESC
In humans embryos can be created during in vitro fertilisation
(IVF). These IVF embryos can be implanted and give rise to off-
spring as seen by the first IVF birth of Louise Brown (Steptoe and
Edwards, 1978). Surplus embryos can be donated for laboratory re-
search. Human ESC are isolated from the Inner Cell Mass of the day
5–6 blastocyst. The blastocyst is a collection of cells derived from
the fertilised egg. The cells of the blastocyst divide and differenti-
ate to form an outer layer referred to as trophectoderm, which will
form the placenta, a feature of mammalian development and the
inner cell mass (ICM) that will form all the somatic cells and the
germ cells of the embryo. The somatic cells form all the cells of
the body, soma, while the germ cells will form the future genera-
tion. ESC cells are derived from the ICM. These ESC cells can form
all the somatic cells of the body found in what are referred to as
three germ layers of the developing embryo, the endoderm, meso-
derm and ectoderm.
From current data, embryonic cells are reset as ‘youthful’
regardless of the age of the donors from which they are derivedyonic stem cells: A model for human ageing in vitro, Exp. Gerontol.
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pluripotency and the ability to continuously divide in culture.
These two characteristics, self-renewal and pluripotency may act
independently of each other. Mouse ESC in long-term culture
showing loss of some pluripotency while maintaining self-renewal
(Li et al., 2007).
Here, we propose a new line of research in ageing where these
human ESC lines can provide a model for human ageing allowing
various environmental factors or genetic manipulation to be tested
to see the effects on potency and replication. In this way ESC may
offer a way of modelling and dissecting human ageing. The use of
these ESC lines for ageing research depends on many biological
markers discussed below.
3. Ageing and biomarkers
One of the problems for ageing research is defining ageing. Life-
span, which is generally thought to be increasing in many human
populations, is a measure of longevity; ageing is synonymous with
health. Biomarkers of ageing often measure the results of ageing
rather than the underlying processes.
Biomarkers need to predict ageing events and ageing may not
necessarily be a degenerative process, merely a developmental
one. Currently, telomeres and telomerase appear to be biomarkers
that not only measure longevity, but may predict the processes of
cellular ageing, senescence. Cell division is found in the early,
‘undifferentiated’ cells whose only function is to provide cells for
the developed compartment that carry out all the functions of
the body. However, the cessation of cellular division is the norm
in the somatic cells which carry out the physiological functions
of the body, even in the ‘youthful’ body. The terminally differenti-
ated, functional cells are supplied by earlier progeny cells that are
themselves provided by Somatic Stem Cells, SSC, found in most
compartments of the foetal and adult body and restricted to pro-
viding progeny in that compartment, i.e. multipotential, rather
than pluripotential as in the ESC.
Nevertheless, cellular senescence, the loss of ability of cells to
divide, is thought to be both a sign of and a cause of ageing in cells.
ESC appear to be able to divide ad infinitum (Carpenter et al.,
2004).
4. Self-renewal
The ability of cells to divide depends on a number of factors
including cell cycle control proteins, telomeres and telomerase
and DNA repair.
4.1. Cell cycle
One of the characteristics of stem cells is their ability to divide
to provide cells for development into functional, mortal differenti-
ated cells. To produce new cells DNA synthesis must occur. The cell
cycle is under strict homeostatic control to match cell division to
cell loss. Cyclins and cyclin-dependent kinases (Cdks) are the major
proteins controlling the cell cycle by phosphorylation of target
genes (Morgan, 1995). Some of the target genes include p53 and
Rb2 tumour suppressors. Both of these prevent the cell progressing
through the cell cycle after damage to the DNA allowing repair or
apoptosis to occur. In contrast to mouse ESC analysis of human ESC
by massive parallel sequencing analysis showed that p53 and
genes such as p16, p19 and p21 that cooperate with p53 are not ex-
pressed or are expressed at very low levels. (Brandenberger et al.,
2004), indicating that the absence of the p53 pathway is required
for human ESC to bypass senescence. Rb and the transcription fac-
tor E2F to which Rb binds to prevent cells entering S phase (Wein-Please cite this article in press as: Cedar, S.H., Minger, S.L., Human embr
(2008), doi:10.1016/j.exger.2008.06.011berg, 1995) and are absent in ESC (Miurra et al., 2004) which may
be the cue to allow ESC to self-renew.
4.2. Telomeres and telomerase in ESC
Telomeres are found at the termini of eukaryotic chromosomes.
They consist of long tandem repeats of TTAGGG sequence and
function to protect chromosomes from fusion and loss of genetic
material, especially during synthesis and division of DNA (Bodner
et al., 1998). They are maintained by an enzyme, telomerase, a
ribonucleoprotein comprising various subunits such as Tert and
Tep1. It is thought that telomeres shorten during each cell division
and that telomerase activity declines during development. Initial
results suggest that telomere lengths and telomerase are main-
tained in ESC (Carpenter et al., 2004). While ESC maintain their tel-
omerase activity, unlike cancer cells and many cells grown in vitro,
they also maintain a normal karyotype (Carpenter et al., 2004).
4.3. DNA repair
During normal metabolism and cell division DNA is susceptible
to damage. Environmental insults, such as UV irradiation and oxi-
dative stress add an extra burden to DNA damage. DNA is repaired
by a panoply of molecules such as endonucleases and ligases. Fail-
ure of this results in senescence, apoptosis or carcinogenesis.
Mouse ESC have been shown to have an efficient defence against
damage by insults such as by free radicals that decreases during
differentiation (Saretzki et al., 2004). Mouse ESC cells are also effi-
cient at p53-independent apoptosis (Aladjem et al., 1998) which
avoids mutation in the cells. In human ESC many repair related
genes are highly expressed (Miurra et al., 2004). In cells including
mouse bone marrow stem cells a cyclin-dependent kinase inhibitor
p16 ink4a appears to be involved in apoptosis caused by stress
such that these stem cells accumulate more of the kinase inhibitor
during ageing and are less able to survive stress (Janzen et al.,
2006). Human ESC may provide a model for testing DNA damage
by, for example, environmental insults and repair mechanisms.
5. Pluripotency
The ability of cells to express the correct proteins to maintain
their role depends on transcription factors, epigenetics and mi-
cro-RNA.
5.1. Transcription Factors
One of the features of ESC is pluripotency, a feature that is lost
during development and maturation. Certain transcription factors
have been shown to be required for the maintenance of pluripoten-
cy in ESC including Oct 4 (Nichols et al., 1998); Nanog (Mitsui et al.,
2003; Chambers et al., 2003) and Sox 2 (Botquin et al., 1998).
Recently somatic cells have been induced to behave in a way
similar to ESC-Induced pluripotent stem cells (iPSC) appear to need
the activation of only four genes to induce this state. In one paper
these four genes are Oct 4, Sox-2, c-Myc and Klf-4 (Takahashi et al.,
2007). Since then Thompson’s laboratory found that Oct -4, Sox-2,
Nanog and Lin28 were needed to transduce their cells (Yu et al.,
2007). How these genes are initially activated and maintained in
ESC or iPSC may help elucidate mechanisms involved in develop-
ment. How they are switched off during development may eluci-
date some mechanisms of ageing. However, the advent of iPSC
challenges basic developmental biology and ageing, that somatic
cells progress through a series of events and die, with only the
germ cells being reset as pluripotential. iPSC allow the possibility
of resetting adult somatic cells. What the gene expression profileyonic stem cells: A model for human ageing in vitro, Exp. Gerontol.
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their expression for example into embryonic forms of genes such
as haemoglobin, has not been explored yet.
5.2. Epigenetics of ESC
Epigenetic mechanisms such as DNA methylation of cytosine in
CpG islands (Bird and Wolff, 1999) post-translational modifica-
tions to histones (Jenuwein and Allis, 2001) and exchange of his-
tones (Ahmad and Henikoff, 2002) may play a large role in gene
expression by inhibition or activation of genes and hence in the
developmental state of cells. Human ESC methylation patterns
are just starting to be investigated.
Maitra et al. (2005) report methylation changes in three genes
known to be altered in cancers. These changes were seen in late
passage human ESC, suggesting that there are genetic changes dur-
ing long-term culturing. In contrast, Rugg-Gunn et al. (2005) have
investigated imprinting in six genes in human ESC without finding
unusual methylation patterns over long passage numbers (be-
tween passage 40 and 155).
5.3. Chromatin
DNA is packaged around histone proteins in the nucleus. His-
tones can be modified by various mechanisms such as acetylation
and methlylation to form transcriptionally open euchromatin
where transcription factors can access and bind to promoter re-
gions or closed, compact heterochromatin which are transcription-
ally inactive. Initial work suggests that pluripotency in ESC may
rely on unique histone modifications (Azuara et al., 2006; Bern-
stein et al., 2006) effecting the gene expression profile of ESC. Elu-
cidating the mechanism of these changes may help understand the
processes occurring during development, commitment, restriction
of potentiality and ageing.
5.4. Micro-RNA
Micro-RNAs (mi-RNAs) are endogenous non-coding small RNA
molecules which negatively regulate gene expression post-trans-
criptionally through mRNA cleavage, mRNA decay (Giraldez et al.,
2006) or translational repression (see Carrington and Ambrose,
2003; Zahn et al., 2007 for review) and were first discovered by
Lee et al. (1993). The expression profile of mi-RNAs differs in ESC
from other tissue (Murchison et al., 2005). Studies have shown that
mi-RNA regulate stem cell division so that stem cells can overcome
the G1/S checkpoint by making stem cells insensitive to an envi-
ronmental signals (Hatfield et al., 2005). Some mi-RNA are un-
iquely expressed in undifferentiated stem cells. There are around
6 (mi-RNA 290–295) with similar sequences found specifically in
ESC, suggesting they may have a role in pluripotency (Houbaviy
et al., 2003). These mi-RNAs may be involved in regulating the
expression of transcription factors such as Oct 4, Sox 2 and Nanog
or other regulators such as Notch. There is evidence in the iPSCs
that a mi-RNA let7a inhibits one of the genes needed for induction,
Lin 28 and it release from inhibition allows self-renewal and pluri-
potency (W. Lensch personal communication 2008).
5.5. Somatic cell nuclear transfer
Somatic Cell Nuclear Transfer (SCNT) has shown that donor nu-
clei can be re-programmed to develop into embryos regardless of
the epigenetic state of the donor nucleus (Wilmut et al., 1997) such
as seen in ‘Dolly the Sheep’. However, this ability may be develop-
mentally and species specific (Kuholzere-Cabot and Brem, 2002).
The ability of older nuclei to be ‘reprogrammed’ by transfer into
the cytoplasm of developmentally early cells implies that thePlease cite this article in press as: Cedar, S.H., Minger, S.L., Human embr
(2008), doi:10.1016/j.exger.2008.06.011cytoplasm may be the site of control of ESC. Micro-RNAs (mi-RNAs)
are potential control factors in epigenesis and gene expression in
ESC (Oakley and Van Zant, 2007). These may hold a key to the
switching on of early transcription factors, chromatin remodelling
and gene expression.
6. Ethics
As mentioned above, germ cells are the ultimate immortal cell
and are of interest in terms of development and ageing. The isola-
tion of unfertilised egg and sperm cells and their use for research is
fraught with problems, as is the use of embryos (Cedar et al., 2006).
Embryonic cells as mentioned are isolated from the ICM of a blas-
tocyst that has been derived from IVF. The eggs and the sperm have
been isolated and fertilisation of the eggs (up to about 30) is per-
formed in vitro. Those eggs that are fertilised and form early blas-
tocysts are used for assisted reproduction to be inserted into the
uterus in the hope of a successful pregnancy. About 25% of IVF
treatments will result in birth. Surplus embryos are frozen for fu-
ture use. Couples having completed their families can then donate
spare embryos or embryos that do not appear suitable for implan-
tation, to research with consent. However, the process of isolating
eggs is costly, not only in money, but also on the burden of time
and medication to the female. The isolation of both eggs and sperm
are intrusive and can be embarrassing. To expect, or exploit, others
for research purposes requires very careful consideration. To use
embryos to help the aged poses many ethical questions. This must
be balanced by the fact that all medical interventions, from, for
example, heart bypasses, insulin replacement therapy or hip
replacement, are to prolong and improve life.7. Models of ageing
Being able to carry out experiments to test how ageing occurs in
humans is impeded due to lack of models. Models of human ageing
are difficult due to the lack of material and the longevity of the spe-
cies. Ageing is often a reflection of multiple divisions and environ-
mental damage. From evidence so far, human ESC appear to have
their genomes re-programmed into an early developmental state
and maintain that state in the presence of the correct environment
even through multiple divisions. Pluripotentiality and self-renewal
are used as functional characteristics for ESC which are the basis of
development and therefore, may define the youthful phenotype.
ESC can provide a source of cells which can be used to model age-
ing. Factors such as genetic or environmental agents can be tested
on these cell populations and changes in biomarkers of ageing
measured. iPSC may also provide a source of cells to test the pro-
cesses and mechanisms of ageing. These ‘youthful’ cells may,
therefore enable us to have the key to the processes of ageing
allowing us to investigate longevity, self-renewal and ageing
mechanisms.
This paper proposes, therefore, that ESC and iPSC may offer a
model of ageing such that the events of longevity can be separated
from the processes and effects of ageing, allowing us to live long
and prosper.
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